
Reset all filters
01 1Pfizer Canada Inc.
02 1Robic
03 1Blank
Reset all filters
01 11208560
02 11339132
03 12802816
Reset all filters
01 1LATANOPROST
02 1Latanoprost
03 1Blank
Reset all filters
01 1Liquid
02 1SOLUTION
03 1Blank
Reset all filters
01 12003-07-29
02 12014-07-29
03 12031-06-28
Patent Expiration Date : 2014-07-29
Date Granted : 1997-07-29
Brand Name : XALATAN
Patent Number : 1339132
Filing Date : 1989-09-12
Strength per Unit : 50mcg / ml
Dosage Form : Liquid
Human Or VET : Human
Route of Administration : Topical (Ophthalmic)
Patent Expiration Date : 2014-07-29
Date Granted : 1997-07-29
Patent Expiration Date : 2003-07-29
Date Granted :
Brand Name :
Patent Number : 1208560
Filing Date :
Strength per Unit :
Dosage Form :
Human Or VET :
Route of Administration :
Patent Expiration Date : 2003-07-29
Date Granted :
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2031-06-28
Date Granted : 2015-05-12
Brand Name : MONOPROST
Patent Number : 2802816
Filing Date : 2011-06-28
Strength per Unit : 0.05 mg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : OPHTHALMIC
Patent Expiration Date : 2031-06-28
Date Granted : 2015-05-12
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF